High-resolution imaging at 3T and 7T with multiring local volume coils

Magnetic resonance (MR) microimaging of the human is becoming increasingly common for studies of tissue microstructure and microfunction. In this study, we consider the constraints that such experiments place on the design of radio-frequency (rf) coils, and describe the advantages of multiring coils, which offer a locally uniform B₁ field. We show that these coils are particularly suitable for high-field imaging of a restricted region of larger experimental animals or humans, offering the same simplicity and efficient use of rf power as a simple surface coil but without requiring sequence modifications such as adiabatic pulses. Imaging results are shown from human brain and from the abdominal aorta of an experimental animal.Acknowledgements. We thank Dr. S. King for his helpful assistance.     

An iron-based T 1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies

A new iron-based T ₁ contrast agent consisting of a complex of iron ions coordinated to phosphate and amine ligands (Fe_(phos) in short) has been characterized by spectroscopic and magnetic measurements. NMR relaxation studies showed r ₁ values to be dependent on the phosphate salt concentration, K₂HPO₄, present in the medium. r ₁ reaches a maximum value of 2.5 mM^?1 s^?1 for measurements carried out at 7 T and 298 K. ³¹P MRS, Mössbauer spectroscopy and magnetic measurements of Fe_(phos) solutions suggest paramagnetic Fe³⁺ ions present in the studied iron–phosphate complex. In vitro and in vivo toxicity experiments with C6 cells and CD1 mice, respectively, demonstrated lack of toxicity for Fe_(phos) at the highest dose tested in the MRI experiments (12 mM iron for C6 cells and 0.32 mmol iron/kg for mice). Finally, T ₁ weighted images of brain tumours in mice have shown positive contrast enhancement of Fe_(phos) for tumour afflicted regions in the brain.     

Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography

The purpose of this study was to compare the efficacy of unenhanced and ferumoxides-enhanced magnetic resonance imaging with that of dual-phase spiral CT and spiral CT during arterial portography (CTAP) for the detection of colorectal liver metastases. Fourteen patients with liver metastases candidates for partial hepatectomy were examined with dual-phase spiral CT, unenhanced and ferumoxides-enhanced MR imaging at 1.5 T, and spiral CTAP. Imaging tests were read blinded, prospectively, quantitating number of lesions excepting CTAP which used US to exclude cysts. Subsequent intraoperative US and pathologic findings were correlated with preoperative imaging results. At surgery, 36 lesions 0.5–13 cm in diameter (mean ±standard deviation, 2.9±2.1 cm) were identified. Dual-phase spiral CT depicted 21/36 (58%); precontrast MR imaging, 19/36 (53%); ferumoxides-enhanced MR imaging, 30/36 (83%); and spiral CTAP, 34/36 (94%) lesions. Ferumoxides-enhanced MR imaging was significantly more sensitive than spiral CT and unenhanced MR imaging (P<0.01). The difference in sensitivity between ferumoxides-enhanced MR imaging and spiral CTAP was not statistically significant (P>0.1). Spiral CTAP, however, depicted nine false-positive lesions (2 hemangiomas, 7 perfusion defects). The positive predictive value was 79% for spiral CTAP and 100% for combined pre- and postcontrast MR imaging. We conclude that ferumoxides-enhanced MR imaging is superior to unenhanced MR imaging and biphasic spiral CT for depiction of colorectal liver metastases. Further investigation is needed to clarify whether MR imaging with use of ferumoxides might replace spiral CTAP for preoperative evaluation of liver resection candidates. Recipient of a Cum Laude award for a scientific exhibit at the 1997 ESMRMB annual meeting.     

Effect of new manganese contrast agent on tissue intensities in human volunteers: comparison of 0.23, 0.6 and 1.5 T MRI,a part of a phase I trial

To evaluate the effect of a new oral manganese contrast agent (CMC-001) on magnetic resonance imaging (MRI) intensities at different magnetic field strengths. Twelve healthy volunteers underwent abdominal MRI 1 week before and within 2.5–4.5 h after CMC-001 (MnCl₂ and absorption promoters dissolved in water) intake at three different MR scanners of 0.23, 0.6 and 1.5 T. Image contrast and intensity enhancement of liver and pancreas were analysed relatively to muscle and fat intensities. Manganese blood levels were followed for 24 h. Whole-blood manganese concentration levels stayed within the normal range. The liver intensities on T2w images decreased about 10% for the 1/2 contrast dose and about 20% for the full contrast dose independent of the field strength. The liver intensities on T1w images increased more than 30% for 1/2 contrast dose and over 40% for full contrast dose. The maximum T1 enhancement was achieved at the highest field. Pancreas intensities were not affected. Contrast between liver, muscle and fat intensities increased with magnetic field, as well as standard errors of the volunteer-averaged intensities. Oral intake of CMC-001 influences liver intensities and does not affect pancreas intensities at different magnetic field strengths.